Editing of the HLA-DR-peptide repertoire by HLA-DM

EMBO Journal

Volumn 15, Issue 22, 1996, Pages 6144-6154

  Kropshofer, Harald ^a   Vogt, Anne B ^a   Moldenhauer, Gerhard ^a   Hammer, Juergen ^b   Blum, Janice S ^c   Hämmerling, Günter J ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b ROCHE MILANO RICERCHE   (Italy)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Antigen presentation; Kinetic proofreading; Mass spectrometry; MHC class II; Peptide binding assay

Indexed keywords

HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; ENDOSOME; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MASS SPECTROMETRY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STABILITY; T LYMPHOCYTE;

EID: 0029858056     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb01002.x     Document Type: Article

References (52)

1. Adams, T.E., Bodmer, J.G. and Bodmer, W.F. (1983) Production and characterization of monoclonal antibodies recognizing the α-chain subunits of human Ia alloantigens. Immunology, 50, 613-624.
2. Avva, R.R. and Cresswell, P. (1994) In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity, 1, 763-774.
3. Bakke, O. and Dobberstein, B. (1990) MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell, 63, 707-715.
4. Bijlmakers, M.-J.E., Benaroch, P. and Ploegh, H.L. (1994) Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med., 180, 623-629.
5. k class II molecules in human APC containing deleted or mutated HLA-DM genes. J. Immunol., 153, 5382-5392.
6. Busch, R., Cloutier, I., Sékaly, R.-P. and Hämmerling, G.J. (1996) Invariant chain protects class II histocotnpatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J., 15, 418-428.
7. Buus, S., Sette, A., Colon, S.M., Jenis, D.M. and Grey, H.M. (1986) Isolation and characterization of antigen-la complexes involved in T cell recognition. Cell, 47, 1071-1077.
8. Chicz, R.M., Urban, R.G., Lane, W.S., Gorga, J.C., Stern, L.J., Vignali, D.A.A. and Strominger, J.L. (1992) Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC related molecules and are heterogeneous in size. Nature, 358, 764-768.
9. Chicz, R.M., Urban, R.G., Gorga, J.C., Vignali, D.A.A., Lane, W.S. and Strominger, J.L. (1993) Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med., 178, 27-47.
10. Cho, S., Attaya, M. and Monaco, J.J. (1991) New class II-like genes in the murine MHC. Nature, 353, 573-576.
11. Denzin, L.K. and Cresswell, P. (1995) HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell. 82, 155-165.
12. Fling, S.P., Arp, B. and Pious, D. (1994) The HLA-DMA gene is required for the formation of stable class II/peptide complexes. Nature, 368, 554-558.
13. Freisewinkel, I.M. Schenck, K. and Koch, N. (1993) The segment of invariant chain that is critical for association with MHC class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl Acad. Sci. USA, 90, 9703-9706.
14. Germain, R.N. (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell, 76, 287-299.
15. Germain, R. and Rinker, Jr. A.G. (1993) Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes selective cell surface expression of occupied molecules. Nature, 363, 725-728.
16. Ghosh, P., Amaya, M., Mellins, E. and Wiley, D.C. (1995) The structure of HLA-DR3 complexed with CLIP, an intermediate in peptide loading. Nature, 387, 457-462.
17. Hammer, J., Takacs, B. and Sinigaglia, F. (1992) Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med., 176, 1007-1013.
18. Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, A. and Sinigaglia, F. (1993) Promiscuous and allele-specific anchors in HLA-DR binding peptides. Cell, 74, 197-203.
19. Hammer, J., Belunis, C., Bolin, D., Papadopoulos, J., Walsky, R., Higelin, J., Danho, W., Sinigaglia, F. and Nagy, Z. (1994) High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc. Natl Acad. Sci. USA, 91, 4456-4460.
20. Kelly, A.P., Monaco, J.J., Cho, S. and Trowsdale, J. (1991) A new human class-II related locus, DM. Nature, 353, 571-573.
21. Kropshofer, H. (1993) Sequences and structural features crucial for the interaction of MHC class II antigens with self- and foreign peptides. Ph.D thesis. Eberhard-Karls-University, Tübingen, Germany.
22. Kropshofer, H., Bohlinger, I., Max, H. and Kalbacher, H. (1991) Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via Trp pockets. Biochemistry, 30, 9177-9187.
23. Kropshofer, H., Max, H., Müller, C.A., Hesse, F., Stevanovic, S., Jung, G. and Kalbacher, H. (1992) Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J. Exp. Med., 175, 1799-1803.
24. Kropshofer, H., Max, H., Halder, T., Kalbus, M., Müller, C.A. and Kalbacher, H. (1993) Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the N-terminus including proline as a stop-signal for trimming. J. Immunol., 151, 4732-4142.
25. Kropshofer, H., Vogt, A.B. and Hammerling, G.J. (1995a) Structural features of invariant chain CLIP region controlling rapid release from HLA-DR molecules and inhibition of peptide binding. Proc. Natl Acad Sci. USA, 92, 8313-8317.
26. Kropshofer, H., Vogt, A.B., Stern, L.J. and Hammerling, G.J. (1995b) Self-release of CLIP in peptide loading of HLA-DR molecules. Science, 270, 1357-1359.
27. Lampson, L.A. and Levy, R. (1980) Two populations of Ia-like molecules on a human B cell line. J. Immunol., 125, 293-299.
28. Lindstedt, R., Liljedahl, M., Péléraux, A., Peterson, P.A. and Karlsson, L. (1995) The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity, 3, 561-572.
29. Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S.L., Quaranta, V. and Peterson, P.A. (1990) Intracellular transport of class II MHC molecules directed by the invariant chain. Nature, 348, 600-605.
30. Marks, M.S., Roche, P.A., van Donselaar, E., Woodruff, L., Peters, P.J. and Bonifacino, J.S. (1995) A lysosomal targeting signal in the cytoplasmic tail of the β chain directs HLA-DM to MHC class II compartments. J. Cell Biol., 131, 351-369.
31. Morris, P., Shaman, J., Attaya, M., Amaya, M., Goodman, S., Bergman, C., Monaco, J.J. and Mellins, E. (1994) An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature, 368, 551-554.
32. O'Sullivan, D. et al. (1991) On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J. Immunol., 147, 2663-2670.
33. Rammensee, H.-G., Friede, T. and Stefanovic, S. (1995) MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228.
34. Riberdy, J.M., Newcomb, J.R., Surman, M.J., Barbosa, J.A. and Cresswell, P. (1992) HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature, 360, 474-477.
35. Roche, P.A. and Cresswell, P. (1990) Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature, 345, 615-618.
36. Roche, P.A. and Cresswell, P. (1991) Proteolysis of the MHC class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl Acad Sci. USA, 88, 3150-3154.
37. Roche, P.A., Marks, M.S. and Cresswell, P. (1991) Formation of a nine subunit complex by HLA class II glycoproteins and the invariant chain. Nature, 354, 392-394.
38. Romagnoli, P. and Germain, R.N. (1994) The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med., 180, 1107-1113.
39. Sadegh-Nasseri, S., Stern, L.J., Wiley, D.C. and Germain, R.N. (1994) MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature, 370, 647-650.
40. Sanderson, F., Kleijmeer, M., Kelly, A., Verwoerd, D., Tulp, A., Neefjes, J., Geuze, H.J. and Trowsdale, J. (1994) Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science, 266, 1566-1569.
41. Sanderson, F., Thomas, C., Neefjes, J. and Trowsdale, J. (1996) Association between HLA-DM and HLA-DR in vivo. Immunity, 4, 87-96.
42. Sette, A. et al. (1992) Invariant chain peptides in most HLA-DR molecules of an antigen processing mutant. Science, 258, 1801-1804.
43. Sette, A., Southwood, S., Miller, J. and Apella, E. (1995) Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med., 181, 677-683.
44. Sherman, M.A., Weber, D.A. and Jensen, P. (1995) DM enhances peptide binding to class II MHC by release of invariant chain-derived peptides. Immunity, 3, 197-205.
45. Sloan, V.S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E. and Zaller, D.M. (1995) Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature, 375, 802-806.
46. Stebbins, C.C., Loss, Jr, G.E., Elias, C.G., Chervonsky, A. and Sant, A.J. (1995) The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J. Exp. Med., 181, 223-234.
47. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L. and Wiley, D.C. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature, 368, 215-221.
48. Urban, R.G., Chicz, R.M. and Strominger, J.L. (1994) Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH. J. Exp. Med., 180, 751-755.
49. Verreck, F.A.W., Vermeulen, C., v.d.Poel, A., Jorritsma, P., Amons, R., Coligan, J.E., Drijfthout, J.W. and Koning, F. (1996) The generation of SDS-stable HLA-DR dimers is independent of efficient peptide binding. Int. Immunol., 8, 397-404.
50. Vogt, A.B., Kropshofer, H., Kalbacher, H., Kalbus, M., Rammensee, H.-G., Coligan, J.E. and Martin, R. (1994) Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J. Immunol., 153, 1665-1673.
51. Vogt, A.B., Stern, L.J., Amshoff, C., Dobberstein, B., Hammerling, G.J. and Kropshofer, H. (1995) Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. J. Immunol., 155, 4757-4765.
52. Vogt, A.B., Kropshofer, H., Moldenhauer, G. and Hammerling, G.J. (1996) Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc. Natl Acad. Sci. USA, 93, 9724-9729.